Walmart is heavily promoting a program of 30-day supplies of generic drugs for $4, pointing to the program as an indicator of the company’s leadership on making healthcare more affordable. To profit on $4 dollar prescriptions, Walmart is importing drugs from foreign countries, including India. One of Walmart’s Indian drug suppliers, Ranbaxy Laboratories, LTD, has been repeatedly investigated by the Food and Drug Administration and the Department of Justice for “inadequate” safeguards against contamination, falsification of records and submitting false information to the FDA.
Banned Drug Company Produces Walmart’s $4 Prescriptions
Published June 25, 2009 Uncategorized Leave a CommentTags: FDA, health, India, prescription drug, safety, Walmart
0 Responses to “Banned Drug Company Produces Walmart’s $4 Prescriptions”